A 75-year-old woman with thoracic spinal cord compression and chloroma (granulocytic sarcoma)

about

A 75-year-old woman with thoracic spinal cord compression and chloroma (granulocytic sarcoma)

Item

http://www.wikidata.org/entity/Q37672497

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

A 75-year-old woman with thora ...... hloroma (granulocytic sarcoma)

@en

A 75-year-old woman with thoracic spinal cord compression and chloroma

@nl

type

Item

label

A 75-year-old woman with thora ...... hloroma (granulocytic sarcoma)

@en

A 75-year-old woman with thoracic spinal cord compression and chloroma

@nl

prefLabel

A 75-year-old woman with thora ...... hloroma (granulocytic sarcoma)

@en

A 75-year-old woman with thoracic spinal cord compression and chloroma

@nl

P1476

A 75-year-old woman with thora ...... hloroma (granulocytic sarcoma)

@en

P2093

Abdalla M Sholi

http://www.w3.org/2001/XMLSchema#string

Alison R Walker

http://www.w3.org/2001/XMLSchema#string

Gloria J Morris

http://www.w3.org/2001/XMLSchema#string

Lloyd E Damon

http://www.w3.org/2001/XMLSchema#string

Madhava Baikaidi

http://www.w3.org/2001/XMLSchema#string

Stephen S Chung

http://www.w3.org/2001/XMLSchema#string

P2860

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Malignant spinal-cord compression.

Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia.

Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine.

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.

Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review.

Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial.

Age and acute myeloid leukemia.

P304

e37-46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.SEMINONCOL.2012.10.002

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Guido Marcucci

Martin S Tallman

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23206848

http://www.w3.org/2001/XMLSchema#string

P932

3969822

http://www.w3.org/2001/XMLSchema#string